TY - JOUR
T1 - Successful treatment of growing teratoma syndrome of the lung by surgical resection
T2 - A case report and literature review
AU - Tanaka, Kensuke
AU - Toyokawa, Gouji
AU - Tagawa, Tetsuzo
AU - Ijichi, Kayo
AU - Haratake, Naoki
AU - Hirai, Fumihiko
AU - Oda, Yoshinao
AU - Maehara, Yoshihiko
N1 - Publisher Copyright:
© 2018 International Institute of Anticancer Research. All rights reserved.
PY - 2018/5
Y1 - 2018/5
N2 - Growing teratoma syndrome (GTS) of the lung is extremely rare, and there are very few reports on this condition. This is a case report of GTS of the lung that was successfully treated by resection. A 19-year-old man, who had been diagnosed with a testicular tumor, lung metastases and left hilar lymph node metastasis, underwent surgical resection for left testicular cancer. After orchiectomy and chemotherapy, the patient was successfully treated with wedge resection of the right upper lobe and left upper lobectomy. In conclusion, the current case suggests that some patients with GTS might be successfully treated by surgical resection.
AB - Growing teratoma syndrome (GTS) of the lung is extremely rare, and there are very few reports on this condition. This is a case report of GTS of the lung that was successfully treated by resection. A 19-year-old man, who had been diagnosed with a testicular tumor, lung metastases and left hilar lymph node metastasis, underwent surgical resection for left testicular cancer. After orchiectomy and chemotherapy, the patient was successfully treated with wedge resection of the right upper lobe and left upper lobectomy. In conclusion, the current case suggests that some patients with GTS might be successfully treated by surgical resection.
UR - http://www.scopus.com/inward/record.url?scp=85046503755&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85046503755&partnerID=8YFLogxK
U2 - 10.21873/anticanres.12571
DO - 10.21873/anticanres.12571
M3 - Article
C2 - 29715149
AN - SCOPUS:85046503755
VL - 38
SP - 3115
EP - 3118
JO - Anticancer Research
JF - Anticancer Research
SN - 0250-7005
IS - 5
ER -
